Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $1.46B | $1.4B | +4.79% |
Cost of Revenue | $958.7M | $937.3M | +2.28% |
Gross Profit | $505.8M | $460.2M | +9.91% |
Operating Income | $260.7M | $249M | +4.70% |
Net Income | $131.8M | $111.3M | +18.42% |
EPS (Basic) | $3.06 | $3.09 | -0.97% |
EPS (Diluted) | $3.05 | $3.06 | -0.33% |
R&D Expense | $35.4M | $35.1M | +0.85% |
SG&A Expense | $183.9M | $169.7M | +8.37% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.95B | $3.49B | +13.28% |
Current Assets | $1.68B | $1.48B | +13.34% |
Total Liabilities | $1.02B | $912.6M | +12.17% |
Current Liabilities | $604.6M | $633.7M | -4.59% |
Stockholders' Equity | $2.93B | $2.58B | +13.67% |
Cash & Equivalents | $509.7M | $446.2M | +14.23% |
Long-Term Debt | $202.6M | $205.8M | -1.55% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $306.5M | $283.2M | +8.23% |
Investing Cash Flow | $-146.5M | $-191.8M | +23.62% |
Financing Cash Flow | $-161.9M | $-489.3M | +66.91% |
Share Buybacks | $134M | $454.1M | -70.49% |
D&A | $81.4M | $74.5M | +9.26% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 34.5% | 32.9% | +1.61% |
Operating Margin | 17.8% | 17.8% | -0.02% |
Net Margin | 9.0% | — | — |
ROE | 4.5% | — | — |
ROA | 3.3% | — | — |
Current Ratio | $2.78 | — | — |
Debt to Equity | $0.349 | — | — |
Other companies in Life Sciences Tools & Services